295 related articles for article (PubMed ID: 36975001)
1. Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential.
Dwir D; Khadimallah I; Xin L; Rahman M; Du F; Öngür D; Do KQ
Int J Neuropsychopharmacol; 2023 May; 26(5):309-321. PubMed ID: 36975001
[TBL] [Abstract][Full Text] [Related]
2. Redox Dysregulation in Schizophrenia Revealed by in vivo NAD+/NADH Measurement.
Kim SY; Cohen BM; Chen X; Lukas SE; Shinn AK; Yuksel AC; Li T; Du F; Öngür D
Schizophr Bull; 2017 Jan; 43(1):197-204. PubMed ID: 27665001
[TBL] [Abstract][Full Text] [Related]
3. Recent Reports on Redox Stress-Induced Mitochondrial DNA Variations, Neuroglial Interactions, and NMDA Receptor System in Pathophysiology of Schizophrenia.
Beeraka NM; Avila-Rodriguez MF; Aliev G
Mol Neurobiol; 2022 Apr; 59(4):2472-2496. PubMed ID: 35083660
[TBL] [Abstract][Full Text] [Related]
4. Brain bioenergetics and redox state measured by
Chouinard VA; Kim SY; Valeri L; Yuksel C; Ryan KP; Chouinard G; Cohen BM; Du F; Öngür D
Schizophr Res; 2017 Sep; 187():11-16. PubMed ID: 28258794
[TBL] [Abstract][Full Text] [Related]
5. Magnetic Resonance Spectroscopy Studies of Brain Energy Metabolism in Schizophrenia: Progression from Prodrome to Chronic Psychosis.
Stein A; Zhu C; Du F; Öngür D
Curr Psychiatry Rep; 2023 Nov; 25(11):659-669. PubMed ID: 37812338
[TBL] [Abstract][Full Text] [Related]
6. The thalamic reticular nucleus in schizophrenia and bipolar disorder: role of parvalbumin-expressing neuron networks and oxidative stress.
Steullet P; Cabungcal JH; Bukhari SA; Ardelt MI; Pantazopoulos H; Hamati F; Salt TE; Cuenod M; Do KQ; Berretta S
Mol Psychiatry; 2018 Oct; 23(10):2057-2065. PubMed ID: 29180672
[TBL] [Abstract][Full Text] [Related]
7. Redox dysregulation, neurodevelopment, and schizophrenia.
Do KQ; Cabungcal JH; Frank A; Steullet P; Cuenod M
Curr Opin Neurobiol; 2009 Apr; 19(2):220-30. PubMed ID: 19481443
[TBL] [Abstract][Full Text] [Related]
8. Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models.
Kulak A; Steullet P; Cabungcal JH; Werge T; Ingason A; Cuenod M; Do KQ
Antioxid Redox Signal; 2013 Apr; 18(12):1428-43. PubMed ID: 22938092
[TBL] [Abstract][Full Text] [Related]
9. Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications.
Ali FT; Abd El-Azeem EM; Hamed MA; Ali MAM; Abd Al-Kader NM; Hassan EA
Schizophr Res; 2017 Oct; 188():98-109. PubMed ID: 28100419
[TBL] [Abstract][Full Text] [Related]
10. Reduction of plasma glutathione in psychosis associated with schizophrenia and bipolar disorder in translational psychiatry.
Nucifora LG; Tanaka T; Hayes LN; Kim M; Lee BJ; Matsuda T; Nucifora FC; Sedlak T; Mojtabai R; Eaton W; Sawa A
Transl Psychiatry; 2017 Aug; 7(8):e1215. PubMed ID: 28892069
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects.
Gubert C; Stertz L; Pfaffenseller B; Panizzutti BS; Rezin GT; Massuda R; Streck EL; Gama CS; Kapczinski F; Kunz M
J Psychiatr Res; 2013 Oct; 47(10):1396-402. PubMed ID: 23870796
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress in bipolar and schizophrenia patients.
Tunçel ÖK; Sarısoy G; Bilgici B; Pazvantoglu O; Çetin E; Ünverdi E; Avcı B; Böke Ö
Psychiatry Res; 2015 Aug; 228(3):688-94. PubMed ID: 26117246
[TBL] [Abstract][Full Text] [Related]
13. Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.
Yao JK; Keshavan MS
Antioxid Redox Signal; 2011 Oct; 15(7):2011-35. PubMed ID: 21126177
[TBL] [Abstract][Full Text] [Related]
14. Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives.
Ermakov EA; Dmitrieva EM; Parshukova DA; Kazantseva DV; Vasilieva AR; Smirnova LP
Oxid Med Cell Longev; 2021; 2021():8881770. PubMed ID: 33552387
[TBL] [Abstract][Full Text] [Related]
15. A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice.
Dean OM; van den Buuse M; Bush AI; Copolov DL; Ng F; Dodd S; Berk M
Curr Med Chem; 2009; 16(23):2965-76. PubMed ID: 19689277
[TBL] [Abstract][Full Text] [Related]
16. The clues in solving the mystery of major psychosis: The epigenetic basis of schizophrenia and bipolar disorder.
Gürel Ç; Kuşçu GC; Yavaşoğlu A; Biray Avcı Ç
Neurosci Biobehav Rev; 2020 Jun; 113():51-61. PubMed ID: 32147531
[TBL] [Abstract][Full Text] [Related]
17. Schizophrenia, Bipolar and Major Depressive Disorders: Overview of Clinical Features, Neurotransmitter Alterations, Pharmacological Interventions, and Impact of Oxidative Stress in the Disease Process.
Mandal PK; Gaur S; Roy RG; Samkaria A; Ingole R; Goel A
ACS Chem Neurosci; 2022 Oct; 13(19):2784-2802. PubMed ID: 36125113
[TBL] [Abstract][Full Text] [Related]
18. Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery.
Reilly JL; Sweeney JA
Schizophr Bull; 2014 May; 40(3):516-22. PubMed ID: 24574307
[TBL] [Abstract][Full Text] [Related]
19. Integrative transcriptome network analysis of iPSC-derived neurons from schizophrenia and schizoaffective disorder patients with 22q11.2 deletion.
Lin M; Pedrosa E; Hrabovsky A; Chen J; Puliafito BR; Gilbert SR; Zheng D; Lachman HM
BMC Syst Biol; 2016 Nov; 10(1):105. PubMed ID: 27846841
[TBL] [Abstract][Full Text] [Related]
20. [Role of oxidative stress in the pathophysiology of neuropsychiatric disorders].
Nunomura A; Tamaoki T; Motohashi N
Seishin Shinkeigaku Zasshi; 2014; 116(10):842-58. PubMed ID: 25672211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
